Granules India appoints Dr PN Baskaran as President - Head API Manufacturing, Operations

Sethu Madhavan is a postgraduate in chemical engineering from ICT Mumbai and an executive MBA from MDI Gurgaon. He has over 27 years of experience in API manufacturing across biologics and small molecules and has worked with organizations like Biocon, Teva API, Ranbaxy, Dr. Reddy’s Laboratories & Herdilla Chemicals. He has handled various functions like R&D, Operations, Technical Services & Technology Transfer, and Operational Excellence activities in the pharmaceutical industry. He joined Granules India in March 2024.

Granules India Limited, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered in Hyderabad. Amongst the few pharmaceutical companies in the world to be present across the manufacturing of the entire pharmaceutical value chain – from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), Granules products are distributed to over 300+ customers in regulated and semiregulated markets with a global presence extending to over 80+ countries with offices across India, US and UK. The Company has 10 manufacturing facilities out of which 8 are located in India and 2 are in the USA and has regulatory approvals from the US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL.